Our findings suggest that NOTCH3 downregulation may reverse the transcriptional repression of VIM to facilitate EMT in ESCC cells, leading to chemotherapy resistance and poor prognosis in ESCC patients. The gene discussed is VIM; the disease is esophageal squamous cell carcinoma.